Enfusion Results Presentation Deck

Q1 2023 key financial highlights $ in millions Highly attractive SaaS model with combination of scale, growth and profitability *:enfusion Total Revenue Gross Profit Adjusted Gross Profit Net Income Adjusted EBITDA (1) Operating Cash Flow (1) Adjusted Free Cash Flow (1) (1) See appendix for definition and non-GAAP reconciliations. $41.0 $27.7 $27.9 $4.7 $5.7 $0.9 $4.5 20.0% YOY Growth 67.5% Gross Margin 68.2% Adjusted Gross Margin 11.5% Net Income Margin 13.9% Adjusted EBITDA Margin 2.3% OCF Margin 79.7% FCF Conversion ©2023 ENFUSION. ALL RIGHTS RESERVED. 10

View entire presentation